VWA1
protein-codingvon Willebrand factor A domain containing 1, the group of Fibronectin type III domain containing
Gene summary
VWA1 belongs to the von Willebrand factor (VWF; MIM 613160) A (VWFA) domain superfamily of extracellular matrix proteins and appears to play a role in cartilage structure and function (Fitzgerald et al., 2002 [PubMed 12062410]).[supplied by OMIM, Nov 2010]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~8.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0030977
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0030977
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0013947
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to VWA1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_022834.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 16 | 5 | 24 | ||
| missense | 2 | 126 | 10 | 1 | 139 | |
| nonsense | 1 | 2 | 3 | |||
| start loss | 0 | |||||
| frameshift | 3 | 12 | 2 | 17 | ||
| splice donor/acceptor (+/-2bp) | 1 | 1 | 2 | |||
| Total | 4 | 17 | 132 | 26 | 6 | 185 |
Highest pathogenic variant AF is 0.0009313573
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_073745.2 | 3 | MANE Select | |
| Ensembl | ENSP00000417185.1 | 3 | MANE Select | |
| RefSeq | NP_954572.2 | 2 | Standard | |
| Ensembl | ENSP00000423404.1 | 2 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Post-translational protein phosphorylation
- Post-translational protein modification
- Metabolism of proteins
- Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
Biological Process
- growth plate cartilage chondrocyte morphogenesis
- extracellular matrix organization
- post-translational protein modification
- cellular protein metabolic process
- behavioral response to pain
Molecular Function
- extracellular matrix structural constituent
- identical protein binding
Cellular Component
- basement membrane
- interstitial matrix
- extracellular space
- endoplasmic reticulum lumen
- extracellular matrix
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000476993
- Coding exons
- 3
- Length
- 8022
- Individuals with no LoFs
- 125110
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 34
- Defined
- 125144
- p
- 0.000136
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.150 | 219 | 213 | 1.03 | 0.0000149 | 2681 |
| Missense (PolyPhen) | 78 | 74.142 | 1.052 | 953 | ||
| Synonymous | 0.320 | 100 | 104 | 0.960 | 0.00000800 | 1052 |
| Loss of Function | 1.43 | 5 | 9.86 | 0.507 | 5.95e-7 | 110 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00032 | 0.00031 | rare |
| Latino/Admixed American | 0.000060 | 0.000058 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000055 | 0.000054 | rare |
| Finnish | 0.000048 | 0.000046 | rare |
| European (Non-Finnish) | 0.00013 | 0.00012 | rare |
| South Asian | 0.00030 | 0.00029 | rare |
| Other | 0.00034 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Promotes matrix assembly. {ECO:0000250|UniProtKB:Q8R2Z5}.;
Recessive Scores
- pRec
- 0.142
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.0208
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |